Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

CureVac establishes RNA printer-specific company

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced that it has established...

Rosatom and Chiesi signed an agreement to acquire “green” I-REC certificates

JSC Atomenergopromsbyt (part of the wind energy division of Rosatom) and the Russian division of the Chiesi Group of Companies (Italy) signed an agreement...

Touchlight and Versameb sign GMP manufacturing supply agreement

Versameb moves forward with its lead asset towards clinical development with an Innovative synthetic doggybone DNA technology which increases quality and yield of mRNA...

Abbott Nutrition recalled more baby formula Similac PM after another report of illness

The U.S. Food and Drug Administration has expanded its recall to include another Similac PM product. The Centers for Disease Control and Prevention (CDC)...

U.S. FDA approves medicine for the treatment of relapsed or refractory multiple myeloma

The Janssen Pharmaceutical Companies of Johnson & Johnson and its China-focused partner Legend Biotech Corp. developed a therapy to treat a type of white blood...

Amorphous Solid Dispersion – a new dosage form

RUDN University scientists together with colleagues from Switzerland proved in a clinical trial the effectiveness of a new dosage form — amorphous solid dispersion....
spot_img

Expert Articles

spot_img